Silexion Therapeutics Corp. (SLXN)

NASDAQ

$0.17

$+0.00

(+2.44%)

Pre-Market

Silexion Therapeutics Corp. (SLXN) Live Price Chart

Last updated: ⁦2026-10-23 13:01:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Silexion Therapeutics Corp. (SLXN) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.17, with a market capitalization of $2.39M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.14 to $35.60. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.39M
Open	$0.16
Day's High	$6,277.50
Day's Low	$0.14
Previous Close	$0.17
Volume	51.54K
Average Volume	10.30M
P/E Ratio	--
52-Week High	$35.60
52-Week Low	$0.14
Dividend Yield	--
Earnings Date	--

Silexion Therapeutics Corp. (SLXN) Pre-Market Stock Price

Silexion Therapeutics Corp. (SLXN) is trading at $0.17 in pre-market trading as of 2026-10-23 12:55:00, up 1.69% ($0.00) from the previous close of $0.17

Pre-market trading shows how investors are pricing SLXN before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Silexion Therapeutics Corp. (SLXN) 7-Day Stock Price Change

Over the past seven days, Silexion Therapeutics Corp. (SLXN) moved from $0.17 to $0.17, representing a decline of 1.75% ($0.00).

The stock traded between $0.14 and $0.20 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 1.63 million shares, up versus the previous seven-day period, indicating higher trading activity.

SLXN 52-Week Price Position

Position in Range: 0.1%

52W Low$0.14

52W High$35.60

SLXN is currently trading at $0.17, placing it 0.1% of the way from its 52-week low of $0.14 to its 52-week high of $35.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Silexion Therapeutics Corp. (SLXN)?

Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for cancers driven by mutations in the mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS). Its proprietary technology is designed to prompt tumor cells to degrade the messenger RNA (mRNA) that bridges the oncogene and the cellular protein synthesis machinery, utilizing small interfering RNA (siRNA) constructs that are chemically modified to enhance stability and cellular uptake while maintaining biological activity that interferes with the mRNA function. Its product candidate, SIL204, is a second-generation siRNA engineered to suppress the production of mutated KRAS proteins.

Silexion Therapeutics Corp. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	13
Exchange	NASDAQ
Company Website	https://silexion.com

How to Buy Silexion Therapeutics Corp. (SLXN) Stock on MEXC

Eligible investors can buy real shares of Silexion Therapeutics Corp. (SLXN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for SLXN and Place Your Order

Open the RealStocks trading page and search for SLXN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Silexion Therapeutics Corp. (SLXN) stock price today?

Silexion Therapeutics Corp. (SLXN) is currently trading at $ 0.17, up 1.69% ($0.00) from the previous close of $ 0.17. Intraday prices update in real time during regular trading hours.

2.Is SLXN stock going up or down today?

As of 2026-10-23 12:55:00, SLXN is trading at $ 0.17, up 1.69% ($0.00) from its previous close of $ 0.17. The stock has traded between $ 0.14 and $ 6,277.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is SLXN pre-market price?

As of 2026-10-23 12:55:00, SLXN is trading at $ 0.17 in pre-market trading, up 1.69% ($0.00) from the previous close of $ 0.17. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is SLXN after-hours price?

As of 2026-10-23 12:55:00, SLXN is trading at $ 0.16 in after-hours trading, down 1.33% ($0.00) from the regular-session close of $ 0.17. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is SLXN stock trading now?

SLXN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does SLXN sit relative to its 52-week high and low?

Over the past 52 weeks, SLXN has traded between a low of $ 0.14 and a high of $ 35.60. At $ 0.17, the stock is positioned 0.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Silexion Therapeutics Corp. in?

Silexion Therapeutics Corp. (SLXN) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Silexion Therapeutics Corp.'s market capitalization and where is it listed?

Silexion Therapeutics Corp. is listed on the NASDAQ exchange with a market capitalization of $ 2.39M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is SLXN valued in terms of P/E ratio and EPS?

SLXN trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Silexion Therapeutics Corp. pay a dividend?

Silexion Therapeutics Corp. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.